MX2009003138A - Composicion que contiene la combinacion de madecasosida y/o de terminolosida y de una arginina y/o una de sus sales y/o uno de sus derivados; utilizacion de la combinacion para inducir y/o estimular el crecimiento de estas fibras queratinicas humanas - Google Patents

Composicion que contiene la combinacion de madecasosida y/o de terminolosida y de una arginina y/o una de sus sales y/o uno de sus derivados; utilizacion de la combinacion para inducir y/o estimular el crecimiento de estas fibras queratinicas humanas

Info

Publication number
MX2009003138A
MX2009003138A MX2009003138A MX2009003138A MX2009003138A MX 2009003138 A MX2009003138 A MX 2009003138A MX 2009003138 A MX2009003138 A MX 2009003138A MX 2009003138 A MX2009003138 A MX 2009003138A MX 2009003138 A MX2009003138 A MX 2009003138A
Authority
MX
Mexico
Prior art keywords
composés
composé
formule
mélange
comprenant
Prior art date
Application number
MX2009003138A
Other languages
English (en)
Inventor
Andre Rougier
Pascale Lazzeri
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal filed Critical Oreal
Publication of MX2009003138A publication Critical patent/MX2009003138A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9794—Liliopsida [monocotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth

Abstract

La presente invención se refiere a una composición para el cuidado de las fibras queratínicas humanas, que comprende en un medio fisiológicamente aceptable: a) uno o más compuestos escogidos entre argininas y/ o sus sales de ácidos orgánicos o minerales y/o sus derivados; b) un compuesto o una mezcla de compuestos de la fórmula (I) siguiente: (ver fórmula (I)) en donde R1 = H o -CH3; R2 = H o -CH3: R3 = -CH3, R1 y R2 no son simultáneamente H o bien un extracto de Centella Asiática que comprende el compuesto o la mezcla de compuestos de la fórmula (I). La invención también se refiere a un proceso de tratamiento cosmético de las fibras queratínicas humanas y/o del cuero cabelludo diseñado para inducir y/o estimular el crecimiento de estas fibras y/o frenar su caída y/o aumentar su densidad.
MX2009003138A 2008-03-28 2009-03-23 Composicion que contiene la combinacion de madecasosida y/o de terminolosida y de una arginina y/o una de sus sales y/o uno de sus derivados; utilizacion de la combinacion para inducir y/o estimular el crecimiento de estas fibras queratinicas humanas MX2009003138A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0852009A FR2929118B1 (fr) 2008-03-28 2008-03-28 Utilisation de l'association de madecassoside et/ou de terminoloside et d'une arginine pour induire et/ou stimuler la croissance de ces fibres keratiniques humaines et/ou freiner leur chute

Publications (1)

Publication Number Publication Date
MX2009003138A true MX2009003138A (es) 2009-10-05

Family

ID=39951719

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009003138A MX2009003138A (es) 2008-03-28 2009-03-23 Composicion que contiene la combinacion de madecasosida y/o de terminolosida y de una arginina y/o una de sus sales y/o uno de sus derivados; utilizacion de la combinacion para inducir y/o estimular el crecimiento de estas fibras queratinicas humanas

Country Status (8)

Country Link
US (1) US20090324526A1 (es)
EP (1) EP2119431B1 (es)
JP (1) JP5815199B2 (es)
CN (1) CN101596152A (es)
BR (1) BRPI0900583B1 (es)
ES (1) ES2657376T3 (es)
FR (1) FR2929118B1 (es)
MX (1) MX2009003138A (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102526742B (zh) * 2012-03-05 2013-07-10 中国药科大学 具有溶酶体逃逸能力的功能性纳米载体及其制备方法
CN103796631A (zh) * 2012-06-29 2014-05-14 生物光谱公司 含有羟基积雪草苷的皮肤美白组合物
FR3117834B1 (fr) * 2020-12-17 2023-11-10 Oreal Composition cosmétique biphase comprenant un acide aminé et deux acides spécifiques
WO2023123046A1 (en) * 2021-12-29 2023-07-06 L'oreal Composition for caring for the skin

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2268523A1 (en) 1974-04-26 1975-11-21 Podrorodecka Maria Treatment of hair loss and dandruff - using compositions contg nystatin, rifamycin and a corticoid
FR2606634B1 (fr) 1986-11-18 1989-03-24 Sorias Christiane Composition notamment pour arreter la chute des cheveux et favoriser leur regeneration et procede pour son obtention
AU618517B2 (en) 1986-12-23 1992-01-02 Eugene J. Van Scott Additives enhancing topical actions of therapeutic agents
FR2609390A1 (fr) * 1987-01-13 1988-07-15 Nogues Pierre Composition capillaire
US4910226A (en) 1987-04-29 1990-03-20 Smithkline Beckman Corporation Steroid 5-alpha-reductase inhibitors
JPH0710722B2 (ja) 1987-11-04 1995-02-08 小野田セメント株式会社 珪酸カルシウムおよびその製造方法
US5480913A (en) 1989-09-27 1996-01-02 Arch Development Corporation Anti-androgen compounds
US5411981A (en) 1991-01-09 1995-05-02 Roussel Uclaf Phenylimidazolidines having antiandrogenic activity
FR2683531B1 (fr) 1991-11-13 1993-12-31 Rhone Poulenc Rorer Sa Nouveaux derives du lupane, leur preparation et les compositions pharmaceutiques qui les contiennent.
AU684470B2 (en) 1992-09-11 1997-12-18 Stb Family Limited Partnership Method and composition for the treatment of hair loss
GB9222772D0 (en) * 1992-10-30 1992-12-09 Unilever Plc Cosmetic composition
DE69429337T3 (de) 1993-04-02 2012-08-30 Anticancer Inc. Verfahren zur verabreichung von förderlichen zusammensetzungen auf die haarfollikel
JPH0710722A (ja) * 1993-06-25 1995-01-13 Kotaku Rin 育毛剤
TW369521B (en) 1993-09-17 1999-09-11 Smithkline Beecham Corp Androstenone derivative
FR2719481B1 (fr) 1994-05-05 1996-05-31 Oreal Composition à base de composés antifongiques et de composés antibactériens halogènes pour diminuer la chute des cheveux.
US5516779A (en) 1994-06-08 1996-05-14 Merck & Co., Inc. 17β-substituted-6-azasteroid derivatives useful as 5α-reductase inhibitors
US5529769A (en) 1994-12-20 1996-06-25 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Cosmetic compositions containing betulinic acid
US5631282A (en) 1995-06-07 1997-05-20 Merck & Co., Inc. Triterpenes
JP3527584B2 (ja) * 1996-01-23 2004-05-17 株式会社ナリス化粧品 養毛・育毛剤
JP4020989B2 (ja) * 1996-03-06 2007-12-12 株式会社ノエビア 血流促進剤及びこれを配合して成る皮膚外用剤
EP1041880B1 (en) * 1997-09-17 2010-01-27 Strategic Science & Technologies, LLC Administration of arginine to warm cool/cold tissue
FR2787996B1 (fr) * 1998-12-30 2002-05-10 Dior Christian Parfums Composition cosmetique ou dermatologique contenant un actif stimulant la synthese de la proteine hsp 32 dans la peau et methode de traitement cosmetique
JP2000327537A (ja) * 1999-05-18 2000-11-28 Noevir Co Ltd 養毛剤及び毛髪用化粧料
FR2794974B1 (fr) 1999-06-16 2001-08-17 Exsymol Sa Composition cosmetique pour l'amincissement a base de l-arginine, d'un analogue de l-arginine ou d'un de leurs derives, applicable par voie topique
US20050226821A1 (en) 2002-02-22 2005-10-13 Jacob Waugh Cosmetic formulations containing l-arginine oligomers
FR2848117B1 (fr) 2002-12-10 2006-08-04 Roche Consumer Health Ltd Procede de preparation d'un extrait de centella asiatica riche en madecassoside et en terminoloside
WO2005123032A2 (en) 2004-06-15 2005-12-29 The Boots Company Plc Haircare compositions and methods
JP4685375B2 (ja) * 2004-06-23 2011-05-18 株式会社ノエビア 皮膚外用剤
DE102004041588A1 (de) * 2004-08-26 2006-03-16 Cos-Tech Parfüm und Kosmetik GmbH Dermatologische Zusammensetzung
WO2006066323A1 (en) * 2004-12-24 2006-06-29 Dolphst Pty Ltd Formulations and treatments for trichology
CA2628694A1 (en) * 2005-11-09 2007-05-18 Bayer Consumer Care Ag Use of compounds from centella asiatica
US8858968B2 (en) * 2005-12-05 2014-10-14 L'oreal Use of tyrosine-arginine dipeptide and niacinamide as substance P antagonist

Also Published As

Publication number Publication date
JP5815199B2 (ja) 2015-11-17
BRPI0900583A2 (pt) 2010-12-14
FR2929118B1 (fr) 2010-05-07
EP2119431A1 (fr) 2009-11-18
US20090324526A1 (en) 2009-12-31
CN101596152A (zh) 2009-12-09
ES2657376T3 (es) 2018-03-05
BRPI0900583B1 (pt) 2022-06-07
EP2119431B1 (fr) 2017-11-15
FR2929118A1 (fr) 2009-10-02
JP2009242396A (ja) 2009-10-22

Similar Documents

Publication Publication Date Title
BRPI0609121B8 (pt) 1h-benzimidazol-4-carboxamidas substituídas com um carbono quaternário na posição 2
GEP20135803B (en) Dioxa-bicyclo[3.2.1.]octane-2,3,4-triol derivatives
BRPI0813925A2 (pt) Utilização de pelo menos uma substância favorecendo a reversão da reação de maillard frente aos ages, método de triagem de princípios ativos favorecendo a deglicação dos ages e composição.
MA31612B1 (fr) Composition pharmaceutique contenant un derive de benzene substitue par glucopyranosyle
BRPI0611717A2 (pt) composto, composiÇço farmacÊutica e uso do composto
BRPI0607703A2 (pt) compostos de isoquinolina e métodos de uso dos mesmos
CL2008003582A1 (es) Uso de una composicion farmaceutica que contiene cisteamina o cistamina en la preparacion de un medicamento util para el tratamiento de una enfermedad de higado graso no alcholico (nafld) o esteatohepatitis no alcoholica (nash).
MX2009003138A (es) Composicion que contiene la combinacion de madecasosida y/o de terminolosida y de una arginina y/o una de sus sales y/o uno de sus derivados; utilizacion de la combinacion para inducir y/o estimular el crecimiento de estas fibras queratinicas humanas
MA27707A1 (fr) Derives aryles et heteroaryles tri-substitues en position 1,2,3 en tant que modulateurs de metabolisme et prophylaxie et traitement de troubles lies au metabolisme
EA200900940A1 (ru) Фармацевтическая композиция, содержащая пиразол-о-глюкозидное производное
MA31502B1 (fr) Anticorps anti-notch 1 specifiques a nrr et ses procedes d'utilisation
CL2007003614A1 (es) Compuestos derivados de sulfonil-fenil-2h-[1,2,4]oxadiazol-5-ona; composicion farmaceutica que comprende a dicho compuesto; procedimiento de preparacion; y uso del compuesto en el tratamiento de trastornos del metabolismo, como diabetes mellitus, dis
WO2008092006A3 (en) Antimicrobial compositions
MX2009003305A (es) Inhibidores de co-transportador de glucosa de sodio 2 y metodo para su uso.
TW200740799A (en) Alpha2C adrenoreceptor agonists
BRPI0815324A2 (pt) "conjugado protêico que contém sacarídeos, processo de separação do conjugado protêico que contém sacarídeos, composição farmacêutica do conjugado protêico que contém sacarídeos, uso do conjugado protêico que contém sacarídeos e composto do conjugado protêico que contém sacarídeos"
MY155695A (en) Quinoxalinedione derivatives
BRPI0414565A (pt) composições farmacêuticas e métodos que compreendem combinações de derivados de 2-alquilideno-19-nor-vitamina d e um bisfosfonato
TW200740452A (en) Therapeutic gastrodia extracts
WO2009038842A3 (en) Methods and compositions to inhibit edema factor and adenylyl cyclase
BRPI0620229B8 (pt) formulações farmaceuticas e processos de produção da ditas formulações
BRPI0905687A2 (pt) "composto da fórmula i ou i', composição farmacêutica, método de tratamento de um paciente com uma doença, uso do composto"
BRPI0606191A2 (pt) compostos de amino e carboxamido tetracìclicos e métodos do seu uso
BRPI0717458A2 (pt) Utilização cosmética por via oral e/ou parenteral da glicosamina e da associação da glicosamina e pelo menos um composto polifenol, processo cosmético, composição para administração oral, e, complemento alimentar ou alimento funcional.
WO2008157404A3 (en) Derivatives of 4-(n-azacycloalkyl) anilides as potassium channel modulators

Legal Events

Date Code Title Description
FG Grant or registration